Intra-arterial route with manipulation of the blood-brain barrier permeability for effective delivery of therapeutics to the brain
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
Universität Hamburg, Dissertation, 2021
- Schlagwort
-
Brain
Blood-brain barrier
Therapeutics
Permeability
- Ereignis
-
Veröffentlichung
- (wo)
-
Hamburg
- (wer)
-
Staats- und Universitätsbibliothek Hamburg Carl von Ossietzky
- (wann)
-
2020
- Urheber
- URN
-
urn:nbn:de:gbv:18-ediss-91914
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
25.03.2025, 13:47 MEZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Chu, Chengyan
- Staats- und Universitätsbibliothek Hamburg Carl von Ossietzky
Entstanden
- 2020
Ähnliche Objekte (12)
Microglial activation and blood–brain barrier permeability in cerebral small vessel disease
Serum-derived factors of breast cancer patients with brain metastases alter permeability of a human blood-brain barrier model
Modulation of the blood-brain barrier
Modulation of the blood-brain barrier
Consequences of blood-brain barrier disruption
Ultrastructural cytochemistry of blood-brain barrier endothelia
Permeability of dopamine D2 receptor agonist hordenine across the intestinal and blood-brain barrier in vitro
Sphingosine-1-phosphate receptor 4 regulates blood-brain barrier permeability and promotes a homeostatic endothelial phenotype
Blood-brain barrier dysfunction and pharmacoresistance of seizures
Evolution of Blood-Brain Barrier Permeability in Subacute Ischemic Stroke and Associations With Serum Biomarkers and Functional Outcome
Transport across the blood-brain barrier: focus on the amyloid beta removal and delivery of therapeutics in Alzheimer's disease
Effect of obesity on blood-brain barrier integrity in ischemic brain using mouse model
Microglial activation and blood–brain barrier permeability in cerebral small vessel disease
Serum-derived factors of breast cancer patients with brain metastases alter permeability of a human blood-brain barrier model
Modulation of the blood-brain barrier
Modulation of the blood-brain barrier
Consequences of blood-brain barrier disruption
Ultrastructural cytochemistry of blood-brain barrier endothelia
Permeability of dopamine D2 receptor agonist hordenine across the intestinal and blood-brain barrier in vitro
Sphingosine-1-phosphate receptor 4 regulates blood-brain barrier permeability and promotes a homeostatic endothelial phenotype
Blood-brain barrier dysfunction and pharmacoresistance of seizures
Evolution of Blood-Brain Barrier Permeability in Subacute Ischemic Stroke and Associations With Serum Biomarkers and Functional Outcome
Transport across the blood-brain barrier: focus on the amyloid beta removal and delivery of therapeutics in Alzheimer's disease
Effect of obesity on blood-brain barrier integrity in ischemic brain using mouse model
Microglial activation and blood–brain barrier permeability in cerebral small vessel disease
Serum-derived factors of breast cancer patients with brain metastases alter permeability of a human blood-brain barrier model
Modulation of the blood-brain barrier
Modulation of the blood-brain barrier
Consequences of blood-brain barrier disruption
Ultrastructural cytochemistry of blood-brain barrier endothelia
Permeability of dopamine D2 receptor agonist hordenine across the intestinal and blood-brain barrier in vitro
Sphingosine-1-phosphate receptor 4 regulates blood-brain barrier permeability and promotes a homeostatic endothelial phenotype
Blood-brain barrier dysfunction and pharmacoresistance of seizures
Evolution of Blood-Brain Barrier Permeability in Subacute Ischemic Stroke and Associations With Serum Biomarkers and Functional Outcome
Transport across the blood-brain barrier: focus on the amyloid beta removal and delivery of therapeutics in Alzheimer's disease